Practice variation in the diagnosis and treatment of osteoporosis: A case for more effective physician education in primary care

Citation
H. Saadi et al., Practice variation in the diagnosis and treatment of osteoporosis: A case for more effective physician education in primary care, J WOMEN H G, 8(6), 1999, pp. 767-771
Citations number
18
Categorie Soggetti
Public Health & Health Care Science","General & Internal Medicine
Journal title
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE
ISSN journal
15246094 → ACNP
Volume
8
Issue
6
Year of publication
1999
Pages
767 - 771
Database
ISI
SICI code
1524-6094(199907/08)8:6<767:PVITDA>2.0.ZU;2-S
Abstract
Bone mineral density (BMD) performed by dual energy x-ray absorptiometry (D EXA) has been used at our institution as a screening test for osteoporosis since 1986. Of 2789 bone densitometry tests done between 1992 and 1996 on w omen aged 51-75 years, 1743 (62.5%) were ordered by general internists (GIM ), endocrinologists (ENDO), rheumatologists (RHEUM), and a metabolic bone d isease specialist (MBDS). We compared the percentage of densitometry tests ordered by GIM, ENDO, RHEUM, and MBDS resulting in one of three possible di agnoses (normal, osteopenia, or osteoporosis). Applying the World Health Or ganization's (WHO) definition of normal (<1 standard deviation [SD] below t he mean for young, adult women), osteopenia (greater than or equal to 1 SD- <2.5 SD below the mean), and osteoporosis (greater than or equal to 2.5 SD below the mean), we found that 34% of patients tested between 1992 and 1996 were osteoporotic, 42% were osteopenic, and 24% had normal bone density re sults. The rate of osteoporosis diagnosis was highest in the MBDS cohort (c hi(2) = 9.19, p = 0.002) compared with patients in the other cohorts. To ex plore trends in management of this condition, a random sample of osteoporot ic women aged 51-75 who had densitometry in 1996 (n = 82) was obtained. Rev iew of medical records revealed that 73% were on some form of osteoporosis treatment (bisphosphonate, estrogen, or calcitonin, with or without calcium and vitamin D supplementation). Treatment rates differed significantly, ho wever, by the ordering physician specialty (96% for MBDS, 63% for ENDO, 75% for RHEUM, and 53% for GIM, chi(3)(df2) = 11.37, p = 0.01). There were no significant differences in selected clinical or demographic characteristics between patients treated by GIM and MBDS. This variation in treatment rate s suggests that an opportunity to enhance primary care physicians' recognit ion and treatment of osteoporosis exists. Making osteoporosis management an educational focus may help narrow differences in practice and improve the effectiveness of a larger number of physicians treating patients with this problem.